Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
companion diagnostic
Biotech
AZ outlines AI-enabled TROP2 biomarker strategy for Daiichi ADC
AZ is using the biomarker in the phase 3 AVANZAR trial, which is evaluating Dato-DXd in combination with Imfinzi and chemo in first-line NSCLC.
Angus Liu
Sep 8, 2024 12:22pm
FDA OKs Illumina's tumor gene test as a companion diagnostic
Aug 28, 2024 12:00pm
Labcorp nets companion Dx OK for Pfizer hemophilia gene therapy
Apr 29, 2024 1:56pm
FDA OKs companion Dx with BioMarin hemophilia gene therapy
Jun 30, 2023 10:35am
FDA OKs Foundation Medicine's companion Dx for Pfizer's Braftovi
Jun 9, 2023 1:08pm
Roche nets FDA approval for HER2-low breast cancer test
Oct 5, 2022 11:30am
